Artia Global Partners’s Ascendis Pharma ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.04M Hold
17,740
– – 0.82% 29
2026
Q2
$4.73M Hold
17,740
– – 0.87% 27
2026
Q1
$4.06M Hold
17,740
– – 0.81% 23
2025
Q4
$3.78M Buy
17,740
+5,500
+45% +$1.14M 0.54% 30
2025
Q3
$2.43M Hold
12,240
– – 0.39% 30
2025
Q2
$2.11M Buy
12,240
+4,800
+65% +$782K 0.51% 23
2025
Q1
$1.16M Hold
7,440
– – 0.29% 30
2024
Q4
$1.02M Hold
7,440
– – 0.37% 35
2024
Q3
$1.11M Hold
7,440
– – 0.3% 33
2024
Q2
$1.01M Sell
7,440
-8,454
-53% -$1.15M 0.2% 35
2024
Q1
$2.4M Buy
+15,894
New +$2.27M 0.48% 23

Other funds holding ASND

Artia Global Partners's ASND Position: Q3 2026 in Review

Artia Global Partners held its Ascendis Pharma (ASND) position steady in Q3 2026 at 17,740 shares worth $4.04M. The position accounts for 0.82% of the portfolio, ranked #29.

Artia Global Partners first reported a position in ASND in Q1 2024 and has held it in 11 quarters since. The position peaked at $4.73M in Q2 2026. 347 funds tracked by Wall St. Rank hold ASND as of Q3 2026.

  • Artia Global Partners held 17,740 shares of Ascendis Pharma worth $4.04M as of Q3 2026.
  • Artia Global Partners left its Ascendis Pharma share count unchanged in Q3 2026.
  • Ascendis Pharma made up 0.82% of Artia Global Partners's portfolio in Q3 2026, its #29 holding.
  • Artia Global Partners first reported a position in Ascendis Pharma in Q1 2024 and has held it in 11 quarters since.
  • Artia Global Partners's Ascendis Pharma position peaked at $4.73M in Q2 2026.
  • 347 funds tracked by Wall St. Rank held Ascendis Pharma as of Q3 2026.

Based on Artia Global Partners's 13F filing for Q3 2026, filed 16 Nov 2026.